Search results for " Pathways"

showing 10 items of 621 documents

Organization of the ophidian amygdala: chemosensory pathways to the hypothalamus.

1999

Although recent studies in squamate reptiles have importantly clarified how chemical information is processed in the reptilian brain, how the amygdala relays chemosensory inputs to the hypothalamus to influence chemically guided behaviors is still poorly documented. To identify these chemosensory pathways, the amygdalo-hypothalamic projections, intra-amygdaloid circuitry and afferents from the lateral cortex (LC) to the amygdala were investigated by injecting conjugated dextran-amines into the hypothalamus, amygdala, and LC of garter snakes. The amygdala was divided into olfactory recipient (ventral anterior and external amygdalae), vomeronasal recipient (nucleus sphericus, NS, and medial a…

Olfactory systemMaleVomeronasal organLateral hypothalamusHypothalamusBiologyAmygdalaCortex (anatomy)Terminology as TopicmedicineImage Processing Computer-AssistedAnimalsCerebral CortexGeneral NeuroscienceColubridaeAnatomyOlfactory PathwaysAmygdalaChemoreceptor CellsOlfactory bulbmedicine.anatomical_structurenervous systemHypothalamusFemaleVomeronasal OrganNeuroscienceNucleusThe Journal of comparative neurology
researchProduct

Focal Lesions within the ventral striato-pallidum abolish attraction for male chemosignals in female mice

2014

In rodents, socio-sexual behaviour is largely mediated by chemosensory cues, some of which are rewarding stimuli. Female mice display an innate attraction towards male chemosignals, dependent on the vomeronasal system. This behaviour likely reflects the hedonic value of sexual chemosignals. The anteromedial aspect of the olfactory tubercle, along with its associated islands of Calleja, receives vomeronasal inputs and sexually-dimorphic vasopressinergic innervation. Thus, we hypothesised that this portion of the ventral striato-pallidum, known to be involved in reward processing, might be important for sexual odorant-guided behaviours. In this study, we demonstrate that lesions of this regio…

Olfactory systemMaleVomeronasal organSexual attractionBiologyMotor ActivityGlobus PallidusBehavioral NeuroscienceMiceSexual Behavior AnimalRewardAnimalsSex AttractantsAnalysis of VarianceSexual attractionOlfactory tubercleOlfactory PathwaysAttractionCorpus StriatumGlobus pallidusVomeronasal systemIslands of CallejaSex AttractantsOlfactory tubercleFemaleIslands of CallejaNeuroscience
researchProduct

Olfactory function in children assessed with psychophysical and electrophysiological techniques

2007

International audience; The olfactory information processing abilities of children undergo changes during early life. The aims of the present study were to describe these changes and to probe for their electrophysiological correlates. These aims were investigated in two experiments. In Experiment 1, responses of 146 subjects (3-12 years) were tested with psychophysical tools. Approximately 2/3 of the subjects completed the olfactory tests ("Sniffin' Sticks"). In Experiment 2, 12 additional subjects (3-10 years) were tested with electrophysiological tools. Event-related potentials (ERPs) were recorded in response to olfactory stimulation with H(2)S. Results from Experiment 1 indicated that d…

Olfactory systemMalemedicine.medical_specialtymedia_common.quotation_subjectOlfactionAudiologyDevelopmental psychology03 medical and health sciencesBehavioral Neuroscience[SCCO]Cognitive science0302 clinical medicineDiscrimination PsychologicalPerceptionPsychophysicsmedicinePsychophysicsReaction TimeHumans030223 otorhinolaryngologyChildEvoked PotentialsComputingMilieux_MISCELLANEOUSmedia_commonAnalysis of Variance[SCCO.NEUR]Cognitive science/NeuroscienceAge FactorsOdor identificationOlfactory PathwaysSmellElectrophysiologyOdorChild PreschoolOdorants[ SCCO.NEUR ] Cognitive science/NeuroscienceFemaleAnalysis of variancePsychology030217 neurology & neurosurgery
researchProduct

Bilateral olfactory deprivation reveals a selective noradrenergic regulatory input to the olfactory bulb.

2001

Unilateral olfactory deprivation in the rat induces changes in the catecholaminergic system of the olfactory bulb. Nevertheless, evidence suggests that unilateral deprivation does not fully prevent stimulation of the deprived bulb. The present report analyses the response of the catecholaminergic system of the olfactory bulb in fully deprived rats obtained by bilateral naris occlusion. The complete deprivation produces more rapid and dramatic changes in both the intrinsic and extrinsic catecholaminergic systems of the olfactory bulb. Intrinsic responses involve a rapid decrease in dopamine-containing cells to about 25% of controls, correlated with a decreased Fos expression in juxtaglomerul…

Olfactory systemOlfactory NerveTyrosine 3-MonooxygenaseDopamineCentral nervous systemOlfactionDopamine beta-HydroxylaseBiologyNorepinephrinemedicineAnimalsSensory deprivationOlfactory memoryRats WistarCatecholaminergicAfferent PathwaysNeuronal PlasticityGeneral NeuroscienceOlfactory tubercleDenervationOlfactory BulbAxonsOlfactory bulbRatsSmellOlfactory Nerve Injuriesmedicine.anatomical_structureFemaleLocus CoeruleusSensory DeprivationNeuroscienceProto-Oncogene Proteins c-fosNeuroscience
researchProduct

A putative social chemosignal elicits faster cortical responses than perceptually similar odorants.

2006

Social chemosignals, so-called pheromones, have recently attracted much attention in that effects on women's psychophysiology and cortical processing have been reported. We here tested the hypothesis that the human brain would process a putative social chemosignal, the endogenous steroid endrostadienone, faster than other odorants with perceptually matched intensity and hedonic characteristics. Chemosensory event-related potentials (ERP) were recorded in healthy women. ERP analyses indicate that androstadienone was processed significantly faster than the control odorants. Androstadienone elicited shorter latencies for all recorded ERP components but most so for the late positivity. This fin…

Olfactory systemVisual perceptionMotion PerceptionCortical processingPheromoneschemistry.chemical_compound0302 clinical medicineAttentionHydrogen SulfideEvoked PotentialsCerebral Cortex0303 health sciencesBrain MappingAndrostadienoneElectroencephalographyHuman brainOlfactory PathwaysMiddle AgedChemoreceptor CellsSmellmedicine.anatomical_structureNeurologyPattern Recognition VisualSex pheromoneSensory Thresholds[ SCCO.NEUR ] Cognitive science/NeuroscienceAndrogensFemalePsychologyERPpsychological phenomena and processesAdultCognitive NeuroscienceOlfactionAndrosterone03 medical and health sciencesmedicinePsychophysicsReaction TimeHumansSocial Behavior030304 developmental biologyCommunicationDose-Response Relationship Drugbusiness.industry[SCCO.NEUR]Cognitive science/NeuroscienceOlfactionAndrostadienesPsychophysiologychemistrybusinessNeuroscience030217 neurology & neurosurgeryPsychomotor PerformanceNeuroImage
researchProduct

The vomeronasal cortex - afferent and efferent projections of the posteromedial cortical nucleus of the amygdala in mice

2013

Most mammals possess a vomeronasal system that detects predominantly chemical signals of biological relevance. Vomeronasal information is relayed to the accessory olfactory bulb (AOB), whose unique cortical target is the posteromedial cortical nucleus of the amygdala. This cortical structure should therefore be considered the primary vomeronasal cortex. In the present work, we describe the afferent and efferent connections of the posteromedial cortical nucleus of the amygdala in female mice, using anterograde (biotinylated dextranamines) and retrograde (Fluorogold) tracers, and zinc selenite as a tracer specific for zinc-enriched (putative glutamatergic) projections. The results show that t…

Olfactory systemVomeronasal organHippocampusBiologyEfferent PathwaysAmygdalaMiceCortex (anatomy)medicineolfactory learningAnimalsEntorhinal Cortextract tracingAfferent PathwaysGeneral NeuroscienceOlfactory tubercleaccessory olfactory bulbAnatomyAmygdalaEntorhinal cortexchemosensorymedicine.anatomical_structurenervous systemIslands of CallejaFemaleVomeronasal OrganpheromonesNeurosciencepsychological phenomena and processesEuropean Journal of Neuroscience
researchProduct

Sexual pheromones and the evolution of the reward system of the brain: the chemosensory function of the amygdala.

2008

The amygdala of all tetrapod vertebrates receives direct projections from the main and accessory olfactory bulbs, and the strong similarities in the organization of these projections suggest that they have undergone a very conservative evolution. However, current ideas about the function of the amygdala do not pay sufficient attention to its chemosensory role, but only view it as the core of the emotional brain. In this study, we propose that both roles of the amygdala are intimately linked since the amygdala is actually involved in mediating emotional responses to chemical signals. The amygdala is the only structure in the brain receiving pheromonal information directly from the accessory …

Olfactory systemVomeronasal organolfactory tuberclevomeronasalAmygdalaModels BiologicalRewardNeural PathwaysmedicineAnimalsHumansOlfactory memorySex AttractantsGeneral NeuroscienceOlfactory tubercleAmygdalaolfactoryBiological EvolutionChemoreceptor CellsVentral tegmental areamedicine.anatomical_structureSex pheromoneIslands of CallejadopamineIslands of CallejaPsychologyNeuroscienceVentral tegmental areaBrain research bulletin
researchProduct

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2…

2012

Abstract Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their pathology. Analysis of larger datasets of mutation carriers should allow further tumor characterization. Methods: We used data from 4,325 BRCA1 and 2,568 BRCA2 mutation carriers to analyze the pathology of invasive breast, ovarian, and contralateral breast cancers. Results: There was strong evidence that the proportion of estrogen receptor (ER)-negative breast tumors decreased with age at diagnosis among BRCA1 (P-trend = 1.2 × 10−5), but increased with age at diagnosis among BRCA2, carriers (P-trend = 6.8 × 10−6). The proportion of triple-negative tumors decreased with age at diagnos…

OncologyPathologyendocrine system diseasesEpidemiologyGenes BRCA2Genes BRCA1Estrogen receptorGene mutation0302 clinical medicineCancer screeningMedicineskin and connective tissue diseasesEstrogen Receptor StatusOvarian Neoplasms0303 health sciencesMiddle Agedfemale genital diseases and pregnancy complications3. Good healthSerous fluidtriple-negative tumorsOncology030220 oncology & carcinogenesisFemaleestrogen receptorAdultmedicine.medical_specialtyBRCA1; BRCA2; breast cancer; estrogen receptor; triple-negative tumorsHereditary cancer and cancer-related syndromes Genetics and epigenetic pathways of disease [ONCOL 1]Breast NeoplasmsArticle03 medical and health sciencesbreast cancerBreast cancerSDG 3 - Good Health and Well-beingTranslational research [ONCOL 3]Internal medicineHumansGenetic Predisposition to DiseaseGenetics and epigenetic pathways of disease Translational research [NCMLS 6]Germ-Line MutationAged030304 developmental biologyHereditary cancer and cancer-related syndromes [ONCOL 1]business.industryCancerBRCA1medicine.diseaseBRCA2Neoplasm GradingbusinessOvarian cancer
researchProduct

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

2012

Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian cancer. A genome-wide association study (GWAS) identified six alleles associated with risk of ovarian cancer for women in the general population. We evaluated four of these loci as potential modifiers of ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Four single-nucleotide polymorphisms (SNPs), rs10088218 (at 8q24), rs2665390 (at 3q25), rs717852 (at 2q31), and rs9303542 (at 17q21), were genotyped in 12,599 BRCA1 and 7,132 BRCA2 carriers, including 2,678 ovarian cancer cases. Associations were evaluated within a retrospective cohort approach. All four loci were associated with ovarian …

Oncologyendocrine system diseases[SDV]Life Sciences [q-bio]Càncer d'ovariDCN PAC - Perception action and controlCohort StudiesBreast cancer0302 clinical medicinebrca1brca2Odds RatioGenetics (clinical)ComputingMilieux_MISCELLANEOUSOvarian NeoplasmsGenetics0303 health scienceseducation.field_of_studyBRCA1 ProteinHazard ratioMiddle Aged3. Good healthovarian cancer030220 oncology & carcinogenesisFemaleAdultHeterozygotemedicine.medical_specialtyHereditary cancer and cancer-related syndromes Genetics and epigenetic pathways of disease [ONCOL 1]PopulationSingle-nucleotide polymorphismBiologyOvarian Neoplasms - geneticsPolymorphism Single NucleotideArticleCàncer de mama03 medical and health sciencesBreast cancerGermline mutationSDG 3 - Good Health and Well-beingTranslational research [ONCOL 3]Ovarian cancerInternal medicineGeneticsmedicineHumansGenetic Predisposition to Diseaseddc:610Genetics and epigenetic pathways of disease Translational research [NCMLS 6]educationRetrospective Studies030304 developmental biologyBRCA2 ProteinHereditary cancer and cancer-related syndromes [ONCOL 1]associationRetrospective cohort studysnpOdds ratioBRCA1 Protein - geneticsmedicine.diseaseBRCA2 Protein - geneticsMutationOvarian cancerbrca2; snp; brca1; association; ovarian cancer
researchProduct

Integration of oncology and palliative care: a Lancet Oncology Commission.

2018

© 2018 Elsevier Ltd Full integration of oncology and palliative care relies on the specific knowledge and skills of two modes of care: the tumour-directed approach, the main focus of which is on treating the disease; and the host-directed approach, which focuses on the patient with the disease. This Commission addresses how to combine these two paradigms to achieve the best outcome of patient care. Randomised clinical trials on integration of oncology and palliative care point to health gains: improved survival and symptom control, less anxiety and depression, reduced use of futile chemotherapy at the end of life, improved family satisfaction and quality of life, and improved use of health-…

Oncologymedicine.medical_specialtyHealth Knowledge Attitudes PracticePalliative careAttitude to DeathAttitude of Health PersonnelMEDLINEMedical Oncology03 medical and health sciences0302 clinical medicineQuality of life (healthcare)nursingMultidisciplinary approachInternal medicineNeoplasmsHealth caremedicinecancerHumans030212 general & internal medicineOncology & CarcinogenesisCooperative BehaviorPatient Care Teambusiness.industryDelivery of Health Care IntegratedPalliative CareMental health3. Good healthIntegrated careClinical trialTreatment OutcomeOncology030220 oncology & carcinogenesisCritical PathwaysQuality of LifeInterdisciplinary CommunicationbusinessThe Lancet. Oncology
researchProduct